Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks

Benoit Trottier, Sharon Walmsley, Jacques Reynes, Peter Piliero, Mary O'Hearn, Mark Nelson, Julio Montaner, Adriano Lazzarin, Jacob Lalezari, Christine Katlama, Keith Henry, David Cooper, Bonaventura Clotet, Keikawus Arastéh, Jean François Delfraissy, Hans Jürgen Stellbrink, Joep Lange, Daniel Kuritzkes, Joseph J. Eron, Calvin CohenTosca Kinchelow, Anne Bertasso, Emily Labriola-Tompkins, Anna Shikhman, Belinda Atkins, Laurence Bourdeau, Christopher Natale, Fiona Hughes, Jain Chung, Denise Guimaraes, Claude Drobnes, Silvia Bader-Weder, Ralph DeMasi, Lynn Smiley, Miklos P. Salgo, N. Buss

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks'. Together they form a unique fingerprint.

Medicine & Life Sciences